Industry Verticals »

All Categories

Insights »

About TMR »

Blood Testing Market

Blood Testing Market (Test Type: Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate Specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin D Testing, Thyroid Stimulating Hormone (TSH) Testing, Serum Nicotine/Cotinine Testing, High Sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing and Other Blood Tests) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025–2035

Blood Testing Market Outlook

  • The global industry was valued at US$ 104.4 Bn in 2024
  • It is projected to grow at a CAGR of 8.2% from 2025 to 2035 and cross US$ 249.7 Bn by the end of 2035

Analysts’ Viewpoint Blood Testing Market

The global blood testing market is driven by several dynamics: the growing rates of chronic and infectious disease including diabetes, cardiovascular disease, and cancer, increase in aging population, and the rising interest in preventive and personalized medicine. At the same time, new technologies such as point‑of‑care (POC) devices, automated technologies, lab‑on‑a‑chip, and artificial intelligence (AI) are creating access to diagnostics on-demand, and revolutionizing the speed and accuracy with which testing can be performed.

Blood Testing Market By Revenue

Nevertheless, there are some key constraints to the blood testing market, including the high cost of advanced testing technologies, complicated, burdensome regulatory requirements and processes, limited access to operational testing in resource-poor developing countries, shortages of trained workforce, and issues with reliability of test results.

Despite the above-mentioned constraints, there are multiple market opportunities in the form of home testing, remote and telehealth, innovative markers and companion diagnostics, access to emerging markets, and increased collaboration amongst manufacturers and technology companies, health system providers, and research institutions to foster Future Innovation and scale

Market Introduction

Blood testing is often used in healthcare where the blood is tested for a variety of purposes including being used to monitor one’s overall health and some health conditions, and also to monitor treatments that include blood tests. Blood tests are part of routine health screenings. They are used to check organ function and immune system activity, to diagnose chronic diseases like diabetes, and to help prevent complications from surgery. Needing a blood test doesn't necessarily mean that healthcare provider suspects something is wrong. In many cases, blood tests are used to confirm that person’s health is stable.

Attribute Detail

Market Drivers
  • Rising prevalence of chronic diseases
  • Rapid technological advancements
  • Expansion of home-based and remote testing platforms

Rising Prevalence of Chronic Diseases Expected to Drive Blood Testing Market Size

The rising prevalence of chronic diseases is expected to boost the blood testing market during the forecast period due to higher demand for regular diagnostics, and monitoring and early detection through blood tests. Blood tests play a crucial role in identifying biomarkers, monitoring disease progression, and aiding treatment plans, and thus are regarded as essential tools to make the optimal diagnostic options available both in the hospital or outpatient settings. For instance, as per an article published by National Center for Biotechnology Information in January 2024, 2,001,140 new cancer cases and 611,720 cancer deaths were projected to occur in the U.S. in 2024 alone. Moreover, as per the data published by International Diabetes Federation in 2025, 589 million adults globally had diabetes, with a predicted global incidence of 11% of adults in 2024..= Furthermore, the escalating aging population globally, who are more vulnerable to chronic diseases, increases the need for routine blood testing. Due to this growing demand, healthcare and diagnostic providers are investing in innovative blood-testing options such as point-of-care testing and lab-based assays that process high volumes, advancing the expansion of the market

Rapid technological advancements Anticipated to Boost Blood Testing Market Expansion

Rapid technological advancements are expected to boost the blood testing market by improving the speed, accuracy, availability, and breadth of diagnostics. Innovative advancements such as point-of-care (POC) testing devices, lab-on-a-chip technologies, automated analyzers, and AI-equipped platforms are making the industry's conventional blood testing much more patient-centric, and helping people in processing testing faster.

These technologies are transforming every aspect of blood testing and reducing turnaround from days to minutes, which greatly improves clinical outcomes by allowing for quicker clinical decisions. Liquid biopsies, molecular diagnostics, and next-generation sequencing (NGS) are ushering in a new era of early diagnosis of diseases such as cancers and genetic disorders through more non-invasive methods as well. The coupling of digital health and cloud computing solutions is enabling remote monitoring, real-time communication, and better engagement with patients.

Glucose Testing Segment Driving Blood Testing Market Growth

Blood Testing Market By Test Type

Glucose testing categorized by the variety of testing options (i.e. blood glucose test strips, glucose tolerance tests, etc.) is driving the blood testing market as it is crucial for the management of diabetes and the early detection of disease in both - clinical and self-monitoring scenarios.

Technologies demonstrating ease of use, such as needle-free devices and real time monitoring systems, are widely accepted by users as they align with patients' preferred approach - patient convenience and the ability to manage blood glucose levels without intervention. In addition, the digital health trends, regulatory landscape, and ongoing product development have supported clinical use, directly encouraging glucose testing to remain the leader of all the blood test types through continued use

Regional Outlook of Blood Testing Market

Blood Testing Market By Region

Attribute Detail
Leading Region
  • North America

North America is dominating the blood testing market. This is due to multiple reasons; North America possesses a developed health system infrastructure, high public health awareness, high reimbursement policies that give patients more access to state-of-the-art diagnostic services. The presence of large market players and their respective reagent kits and lab significant ease availability to blood testing.

The increasing awareness of early disease detection and regular health screening will drive demand for blood tests in North America. Furthermore, the development in blood testing technology, and focus on management of chronic diseases encourages both - the demand for blood-testing as well as the blood-testing market's activity and an innovative environment

The high CAGR in the Asia-Pacific blood testing industry is mainly attributed to a combination of rising healthcare demands, technological advancements, and evolving public health initiatives. A significant rise in the incidences of chronic and infectious diseases such as diabetes, cardiovascular diseases, and cancer, and bloodstream infections has caused increased demand for early diagnosis and accurate diagnostics. Additionally, rapid urbanization and increasing access of healthcare many governments of countries in the Asia-Pacific region are investing in more prominent diagnostic infrastructure to support public health has created market opportunities

Analysis of Key Players in Blood Testing Market

Abbott, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Bio‑Rad Laboratories, BIOMÉRIEUX, Quest Diagnostics, Grifols, S.A, Sysmex Corporation, Guardant Health, GRAIL, Inc., Everlywell, Freenome Holdings, Inc., Hologic, Inc., Trinity Biotech are the key players governing the global blood testing market.

Each of these players has been profiled in the blood testing industry research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In May 2025, Fujirebio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its LumipulseG pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for assessing amyloid pathology in patients being evaluated for Alzheimer’s disease and the other causes of cognitive decline. The test is the first FDA-cleared blood-based IVD test in the U.S. to aid in identifying patients with amyloid pathology associated with Alzheimer’s Disease (AD)
  • In December 2024, BD (Becton, Dickinson and Company), and Babson Diagnostics announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings
  • In July 2024, Guardant Health, Inc. announced that it had approved the company’s Shield blood test for colorectal cancer (CRC) screening in adults aged 45 and above who are at average risk for the disease. It is the first blood test to be approved by the U.S. FDA as a primary screening option for CRC, meaning healthcare providers can offer Shield in a manner similar to all the other non-invasive methods recommended in screening guidelines. Shield is also the first blood test for CRC screening that meets the requirements for Medicare coverage

Blood Testing Market Snapshot

Attribute Detail
Size in 2024 US$ 104.4Bn
Forecast Value in 2035 More than US$ 249.7 Bn
CAGR 8.2%
Forecast Period 2025-2035
Historical Data Available for 2020-2023
Quantitative Units US$ Bn
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation By Test Type
  • Glucose Testing
  • A1C Testing
  • Direct LDL Testing
  • Lipid Panel Testing
  • Prostate Specific Antigen Testing
  • COVID-19 Testing
  • BUN Testing
  • Vitamin D Testing
  • Thyroid Stimulating Hormone (TSH) Testing
  • Serum Nicotine/Cotinine Testing
  • High Sensitivity CRP Testing
  • Testosterone Testing
  • ALT Testing
  • Cortisol Testing
  • Creatinine Testing
  • AST Testing
  • Other Blood Tests
By Method
  • Manual Blood Testing
  • Automated Blood Testing
By End-user
  • Hospitals
  • Diagnostic Centers
  • Research laboratories
  • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • Russia
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Abbott
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific Inc.
  • Bio‑Rad Laboratories
  • BIOMÉRIEUX
  • Quest Diagnostics
  • Grifols, S.A
  • Sysmex Corporation
  • Guardant Health
  • GRAIL, Inc.
  • Everlywell
  • Freenome Holdings, Inc
  • Hologic, Inc.
  • Trinity Biotech
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global blood testing market in 2024?

It was valued at US$ 104.4 Bn in 2024

What is the projected size of the blood testing market by 2035?

It is projected to cross US$ 249.7 Bn by the end of 2035

What are the factors driving the blood testing market?

Rising prevalence of chronic diseases, rapid technological advancements, and expansion of home-based and remote testing platforms

What is the blood testing market expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 8.2% from 2025 to 2035

Which region is expected to dominate the blood testing market during the forecast period?

North America blood testing industry is expected to account for the largest share from 2025 to 2035

Who are the prominent blood testing providers?

Abbott, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Bio‑Rad Laboratories, BIOMÉRIEUX, Quest Diagnostics, Grifols, S.A, Sysmex Corporation, Guardant Health, GRAIL, Inc., Everlywell, Freenome Holdings, Inc., Hologic, Inc., Trinity Biotech, and others

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary : Global Blood Testing Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Blood Testing Market Analysis and Forecasts, 2020 - 2035
      • Market Revenue Projections (US$ Bn)
  5. Key Insights
    • Regulatory Landscape across Key Regions / Countries
    • Market Trends
    • PORTER’s Five Forces Analysis
    • PESTEL Analysis
    • Key Purchase Metrics for End-users
    • Brand and Pricing Analysis
    • Key Industry Events
    • Go to Marketing Strategies
  6. Global Blood Testing Market Analysis and Forecasts, By Test Type
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast By Test Type, 2020 - 2035
      • Glucose Testing
      • A1C Testing
      • Direct LDL Testing
      • Lipid Panel Testing
      • Prostate Specific Antigen Testing
      • COVID-19 Testing
      • BUN Testing
      • Vitamin D Testing
      • Thyroid Stimulating Hormone (TSH) Testing
      • Serum Nicotine/Cotinine Testing
      • High Sensitivity CRP Testing
      • Testosterone Testing
      • ALT Testing
      • Cortisol Testing
      • Creatinine Testing
      • AST Testing
      • Other Blood Tests
    • Market Attractiveness By Test Type
  7. Global Blood Testing Market Analysis and Forecasts, By Method
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast By Method, 2020 - 2035
      • Manual Blood Testing
      • Automated Blood Testing
    • Market Attractiveness By Method
  8. Global Blood Testing Market Analysis and Forecasts, By End-user
    • Introduction & Definition
    • Key Findings / Developments
    • Market Value Forecast By End-user, 2020 - 2035
      • Hospitals
      • Diagnostic Centers
      • Research laboratories
      • Others
    • Market Attractiveness By End-user
  9. Global Blood Testing Market Analysis and Forecasts, By Region
    • Key Findings
    • Market Value Forecast By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness By Country/Region
  10. North America Blood Testing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast By Test Type, 2020 - 2035
      • Glucose Testing
      • A1C Testing
      • Direct LDL Testing
      • Lipid Panel Testing
      • Prostate Specific Antigen Testing
      • COVID-19 Testing
      • BUN Testing
      • Vitamin D Testing
      • Thyroid Stimulating Hormone (TSH) Testing
      • Serum Nicotine/Cotinine Testing
      • High Sensitivity CRP Testing
      • Testosterone Testing
      • ALT Testing
      • Cortisol Testing
      • Creatinine Testing
      • AST Testing
      • Other Blood Tests
    • Market Value Forecast By Method, 2020 - 2035
      • Manual Blood Testing
      • Automated Blood Testing
    • Market Value Forecast By End-user, 2020 - 2035
      • Hospitals
      • Diagnostic Centers
      • Research laboratories
      • Others
    • Market Value Forecast By Country/Sub-region, 2020 - 2035
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Test Type
      • By Method
      • By End-user
      • By Country
  11. Europe Blood Testing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast By Test Type, 2020 - 2035
      • Glucose Testing
      • A1C Testing
      • Direct LDL Testing
      • Lipid Panel Testing
      • Prostate Specific Antigen Testing
      • COVID-19 Testing
      • BUN Testing
      • Vitamin D Testing
      • Thyroid Stimulating Hormone (TSH) Testing
      • Serum Nicotine/Cotinine Testing
      • High Sensitivity CRP Testing
      • Testosterone Testing
      • ALT Testing
      • Cortisol Testing
      • Creatinine Testing
      • AST Testing
      • Other Blood Tests
    • Market Value Forecast By Method, 2020 - 2035
      • Manual Blood Testing
      • Automated Blood Testing
    • Market Value Forecast By End-user, 2020 - 2035
      • Hospitals
      • Diagnostic Centers
      • Research laboratories
      • Others
    • Market Value Forecast By Country/Sub-region, 2020 - 2035
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Test Type
      • By Method
      • By End-user
      • By Country/Sub-region
  12. Asia Pacific Blood Testing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast By Test Type, 2020 – 2035
      • Glucose Testing
      • A1C Testing
      • Direct LDL Testing
      • Lipid Panel Testing
      • Prostate Specific Antigen Testing
      • COVID-19 Testing
      • BUN Testing
      • Vitamin D Testing
      • Thyroid Stimulating Hormone (TSH) Testing
      • Serum Nicotine/Cotinine Testing
      • High Sensitivity CRP Testing
      • Testosterone Testing
      • ALT Testing
      • Cortisol Testing
      • Creatinine Testing
      • AST Testing
      • Other Blood Tests
    • Market Value Forecast By Method, 2020 - 2035
      • Manual Blood Testing
      • Automated Blood Testing
    • Market Value Forecast By End-user, 2020 - 2035
      • Hospitals
      • Diagnostic Centers
      • Research laboratories
      • Others
    • Market Value Forecast By Country/Sub-region, 2020 - 2035
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Test Type
      • By Method
      • By End-user
      • By Country/Sub-region
  13. Latin America Blood Testing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast By Test Type, 2020 - 2035
      • Glucose Testing
      • A1C Testing
      • Direct LDL Testing
      • Lipid Panel Testing
      • Prostate Specific Antigen Testing
      • COVID-19 Testing
      • BUN Testing
      • Vitamin D Testing
      • Thyroid Stimulating Hormone (TSH) Testing
      • Serum Nicotine/Cotinine Testing
      • High Sensitivity CRP Testing
      • Testosterone Testing
      • ALT Testing
      • Cortisol Testing
      • Creatinine Testing
      • AST Testing
      • Other Blood Tests
    • Market Value Forecast By Method, 2020 - 2035
      • Manual Blood Testing
      • Automated Blood Testing
    • Market Value Forecast By End-user, 2020 - 2035
      • Hospitals
      • Diagnostic Centers
      • Research laboratories
      • Others
    • Market Value Forecast By Country, 2020 - 2035
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Test Type
      • By Method
      • By End-user
      • By Country
  14. Middle East & Africa Blood Testing Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast By Test Type, 2020 - 2035
      • Glucose Testing
      • A1C Testing
      • Direct LDL Testing
      • Lipid Panel Testing
      • Prostate Specific Antigen Testing
      • COVID-19 Testing
      • BUN Testing
      • Vitamin D Testing
      • Thyroid Stimulating Hormone (TSH) Testing
      • Serum Nicotine/Cotinine Testing
      • High Sensitivity CRP Testing
      • Testosterone Testing
      • ALT Testing
      • Cortisol Testing
      • Creatinine Testing
    • Market Value Forecast By Method, 2020 - 2035
      • Manual Blood Testing
      • Automated Blood Testing
    • Market Value Forecast By End-user, 2020 - 2035
      • Hospitals
      • Diagnostic Centers
      • Research laboratories
      • Others
    • Market Value Forecast By Country/Sub-region, 2020 - 2035
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Test Type
      • By Method
      • By End-user
      • By Country/Sub-region
  15. Competition Landscape
    • Market Player – Competition Matrix (By Tier and Size of companies)
    • Market Share Analysis By Company (2024)
    • Company Profiles
      • Abbott
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bio Rad Laboratories
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • BIOMÉRIEUX
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Quest Diagnostics
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Grifols, S.A
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Sysmex Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Guardant Health
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • GRAIL, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Everlywell
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Freenome Holdings, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Hologic, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Trinity Biotech
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Blood Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
Table 02: Global Blood Testing Market Value (US$ Bn) Forecast, by Method, 2020 to 2035
Table 03: Global Blood Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 04: Global Blood Testing Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 05: North America Blood Testing Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 06: North America Blood Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
Table 07: North America Blood Testing Market Value (US$ Bn) Forecast, by Method, 2020 to 2035
Table 08: North America Blood Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 09: Europe Blood Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 10: Europe Blood Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
Table 11: Europe Blood Testing Market Value (US$ Bn) Forecast, by Method, 2020 to 2035
Table 12: Europe Blood Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 13: Asia Pacific Blood Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 14: Asia Pacific Blood Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
Table 15: Asia Pacific Blood Testing Market Value (US$ Bn) Forecast, by Method, 2020 to 2035
Table 16: Asia Pacific Blood Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 17: Latin America Blood Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 18: Latin America Blood Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
Table 19: Latin America Blood Testing Market Value (US$ Bn) Forecast, by Method, 2020 to 2035
Table 20: Latin America Blood Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 21: Middle East & Africa Blood Testing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 22: Middle East & Africa Blood Testing Market Value (US$ Bn) Forecast, By Test Type, 2020 to 2035
Table 23: Middle East & Africa Blood Testing Market Value (US$ Bn) Forecast, by Method, 2020 to 2035
Table 24: Middle East & Africa Blood Testing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

Figure 01: Global Blood Testing Market Value Share Analysis, By Test Type, 2024 and 2035
Figure 02: Global Blood Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
Figure 03: Global Blood Testing Market Revenue (US$ Bn), by Glucose Testing, 2020 to 2035
Figure 04: Global Blood Testing Market Revenue (US$ Bn), by A1C Testing, 2020 to 2035
Figure 05: Global Blood Testing Market Revenue (US$ Bn), by Direct LDL Testing, 2020 to 2035
Figure 06: Global Blood Testing Market Revenue (US$ Bn), by Lipid Panel Testing, 2020 to 2035
Figure 07: Global Blood Testing Market Revenue (US$ Bn), by Prostate Specific Antigen Testing, 2020 to 2035
Figure 08: Global Blood Testing Market Revenue (US$ Bn), by COVID-19 Testing, 2020 to 2035
Figure 09: Global Blood Testing Market Revenue (US$ Bn), by BUN Testing, 2020 to 2035
Figure 10: Global Blood Testing Market Revenue (US$ Bn), by Vitamin D Testing, 2020 to 2035
Figure 11: Global Blood Testing Market Revenue (US$ Bn), by Thyroid Stimulating Hormone (TSH) Testing, 2020 to 2035
Figure 12: Global Blood Testing Market Revenue (US$ Bn), by Serum Nicotine/Cotinine Testing, 2020 to 2035
Figure 13: Global Blood Testing Market Revenue (US$ Bn), by High Sensitivity CRP Testing, 2020 to 2035
Figure 14: Global Blood Testing Market Revenue (US$ Bn), by Testosterone Testing, 2020 to 2035
Figure 15: Global Blood Testing Market Revenue (US$ Bn), by ALT Testing, 2020 to 2035
Figure 16: Global Blood Testing Market Revenue (US$ Bn), by Cortisol Testing, 2020 to 2035
Figure 17: Global Blood Testing Market Revenue (US$ Bn), by Creatinine Testing, 2020 to 2035
Figure 18: Global Blood Testing Market Revenue (US$ Bn), by AST Testing, 2020 to 2035
Figure 19: Global Blood Testing Market Revenue (US$ Bn), by Other Blood Tests, 2020 to 2035
Figure 20: Global Blood Testing Market Value Share Analysis, by Method, 2024 and 2035
Figure 21: Global Blood Testing Market Attractiveness Analysis, by Method, 2025 to 2035
Figure 22: Global Blood Testing Market Revenue (US$ Bn), by Manual Blood Testing, 2020 to 2035
Figure 23: Global Blood Testing Market Revenue (US$ Bn), by Automated Blood Testing, 2020 to 2035
Figure 24: Global Blood Testing Market Value Share Analysis, by End-user, 2024 and 2035
Figure 25: Global Blood Testing Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 26: Global Blood Testing Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
Figure 27: Global Blood Testing Market Revenue (US$ Bn), by Diagnostic Centers , 2020 to 2035
Figure 28: Global Blood Testing Market Revenue (US$ Bn), by Research Laboratories , 2020 to 2035
Figure 29: Global Blood Testing Market Revenue (US$ Bn), by Others , 2020 to 2035
Figure 30: Global Blood Testing Market Value Share Analysis, By Region, 2024 and 2035
Figure 31: Global Blood Testing Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 32: North America Blood Testing Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 33: North America Blood Testing Market Value Share Analysis, by Country, 2024 and 2035
Figure 34: North America Blood Testing Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 35: North America Blood Testing Market Value Share Analysis, By Test Type, 2024 and 2035
Figure 36: North America Blood Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
Figure 37: North America Blood Testing Market Value Share Analysis, by Method, 2024 and 2035
Figure 38: North America Blood Testing Market Attractiveness Analysis, by Method, 2025 to 2035
Figure 39: North America Blood Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 40: North America Blood Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 41: Europe Blood Testing Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 42: Europe Blood Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 43: Europe Blood Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 44: Europe Blood Testing Market Value Share Analysis, By Test Type, 2024 and 2035
Figure 45: Europe Blood Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
Figure 46: Europe Blood Testing Market Value Share Analysis, by Method, 2024 and 2035
Figure 47: Europe Blood Testing Market Attractiveness Analysis, by Method, 2025 to 2035
Figure 48: Europe Blood Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 49: Europe Blood Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 50: Asia Pacific Blood Testing Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 51: Asia Pacific Blood Testing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 52: Asia Pacific Blood Testing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 53: Asia Pacific Blood Testing Market Value Share Analysis, By Test Type, 2024 and 2035
Figure 54: Asia Pacific Blood Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
Figure 55: Asia Pacific Blood Testing Market Value Share Analysis, by Method, 2024 and 2035
Figure 56: Asia Pacific Blood Testing Market Attractiveness Analysis, by Method, 2025 to 2035
Figure 57: Asia Pacific Blood Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 58: Asia Pacific Blood Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 59: Latin America Blood Testing Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 60: Latin America Blood Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 61: Latin America Blood Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 62: Latin America Blood Testing Market Value Share Analysis, By Test Type, 2024 and 2035
Figure 63: Latin America Blood Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
Figure 64: Latin America Blood Testing Market Value Share Analysis, by Method, 2024 and 2035
Figure 65: Latin America Blood Testing Market Attractiveness Analysis, by Method, 2025 to 2035
Figure 66: Latin America Blood Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 67: Latin America Blood Testing Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 68: Middle East & Africa Blood Testing Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 69: Middle East & Africa Blood Testing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 70: Middle East & Africa Blood Testing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 71: Middle East & Africa Blood Testing Market Value Share Analysis, By Test Type, 2024 and 2035
Figure 72: Middle East & Africa Blood Testing Market Attractiveness Analysis, By Test Type, 2025 to 2035
Figure 73: Middle East & Africa Blood Testing Market Value Share Analysis, by Method, 2024 and 2035
Figure 74: Middle East & Africa Blood Testing Market Attractiveness Analysis, by Method, 2025 to 2035
Figure 75: Middle East & Africa Blood Testing Market Value Share Analysis, By End-user, 2024 and 2035
Figure 76: Middle East & Africa Blood Testing Market Attractiveness Analysis, By End-user, 2025 to 2035

Copyright © Transparency Market Research, Inc. All Rights reserved

Blood Testing Market

Schedule a Call